Meeting
2019 ASCO Annual Meeting
Assessing the potential of immunotherapy in treating chronic lymphocytic leukemia through meta-analysis.
Authors
Jihad Aljabban
The Ohio State University College of Medicine, Columbus, OH
Jihad Aljabban , David Allen , Sean McDermott , Ross Wanner , Hussam Salhi , Saad A Syed , David Chen , Dexter Hadley , Dania Khoulani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Chronic Lymphocytic Leukemia (CLL) and Hairy Cell
Citation
J Clin Oncol 37, 2019 (suppl; abstr 7531)
DOI
10.1200/JCO.2019.37.15_suppl.7531
Abstract #
7531
Poster Bd #
285
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Expanding immunotherapy options in cholangiocarcinoma: Role of CD27 agonist in combination with PD-L1 and MEK inhibition on antitumor effect and CD8+ T cells.
First Author: Frances Jenkins Bennett
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Sex-based differences in the transcriptomic metabolic profiling in young onset colorectal cancer (YOCRC).
First Author: Deepak Vadehra
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri
Poster
2022 ASCO Annual Meeting
Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
First Author: Annika Lenz